Teva Pharmaceutical Industries reported $16.91B in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Aspen Pharmacare ZAR 32.94B 3.18B Dec/2025
Cipla INR 6.14B 1.76B Mar/2026
Dr.Reddys Laboratories INR 71.95B 5.39B Jun/2026
Guangzhou Baiy CNY 18.45B 3.13B Mar/2026
Jiangsu Hengrui CNY 74.23M 17.2M Dec/2025
Kalbe Farma IDR 304.26B 475.72B Mar/2026
Richter Gedeon HUF 21.74B 1.93B Dec/2024
Sh Fosun Pharma CNY 38.09B 1.1B Dec/2025
Sun Pharmaceuticals INR 46.27B 22.65B Mar/2026
Teva Pharmaceutical Industries USD 16.91B 187M Mar/2026